Antioxidants improve impaired insulin-mediated glucose uptake and prevent migration and proliferation of cultured rabbit coronary smooth muscle cells induced by high glucose

Circulation

Volumn 99, Issue 10, 1999, Pages 1370-1378

  Yasunari, Kenichi ^a   Kohno, Masakazu ^a   Kano, Hiroaki ^a   Yokokawa, Koji ^a   Minami, Mieko ^a   Yoshikawa, Junichi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Antioxidants; Insulin; Muscle, smooth; Phospholipase; Protein kinase

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; CALPHOSTIN; GLUCOSE; INSULIN; PHOSPHOLIPASE; PLATELET DERIVED GROWTH FACTOR; PROBUCOL; PROTEIN KINASE; SURAMIN;

ANIMAL CELL; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROGENESIS; CELL FRACTIONATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; FLOW CYTOMETRY; GLUCOSE INTAKE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT SYSTEM; INSULIN METABOLISM; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RABBIT; SMOOTH MUSCLE FIBER;

EID: 0033574236     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.10.1370     Document Type: Article

References (26)

1. Stein B, Weintraub WS, Gebhart SSP, Cohen-Bernstein CL, Grosswald R, Liberman HA, Douglas JS Jr, Morris DC, King SB III. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation. 1995;91:979-989.
2. Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med. 1986;314:488-500.
3. Williamson JR, Chang K, Frongos M, Hasan KS, Ido Y, Kawamura T, Nyengaard JR, Enden MVD, Kilo C, Tilton RG. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes. 1993;42:801-813.
4. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes. 1991;40:405-412.
5. Parthasarathy S, Young SG, Witztum L, Pittman RC, Steinberg D. Probucol inhibits oxidative modification of low density lipoprotein. J Clin Invest. 1986;77:641-644.
6. Machlin LJ, Bendich A. Free radical tissue damage: protective role of antioxidant nutrients. FASEB J. 1987;1:441-445.
7. Rao GN, Berk BC. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ Res. 1992;70: 593-599.
8. Després J-P, Lamarche B, Mauriège P, Cantin B, Dagenais GR, Moorjani S, Lupien P-J. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996;334:952-957.
9. Kellerer M, Kroder G, Tippmer S, Berti L, Kiehn R, Mosthaf L, Häing H. Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts. Diabetes. 1994;43:447-453.
10. Saltiel AR, Olefsky JM. Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes. 1996;45:1661-1669.
11. King GL, Buzney SM, Kahn CR, Hetu N. Differential responsiveness to insulin of endothelial support cells from micro- and macrovessels. J Clin Invest. 1983;71:974-979.
12. Yasunari K, Kohno M, Kano H, Yokokawa K, Horio T, Yoshikawa J. Possible involvement of phospholipase D and protein kinase C in vascular growth induced by elevated glucose concentration. Hypertension. 1996; 28:159-168.
13. Yasunari K, Kohno M, Kano H, Yokokawa K, Minami M, Yoshikawa J. Mechanisms of action of troglitazone in the prevention of high glucose-induced migration and proliferation of cultured coronary smooth muscle cells. Circ Res. 1997;81:953-962.
14. Yasunari K, Kohno M, Kano H, Yokokawa K, Horio T, Yoshikawa J. Aldose reductase inhibitor prevents hyperproliferation and hypertrophy of cultured rat vascular smooth muscle cells induced by high glucose. Arterioscler Thromb Vasc Biol. 1995;15:2207-2212.
15. Bass DA, Parce JW, Dechatelet LR, Szejda P, Seeds MC, Thomas M. Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J Immunol. 1983;130: 1910-1917.
16. Wallenstein SW, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res. 1980;47:1-9.
17. 2 for platelet-derived growth factor signal transduction. Science. 1995;270:296-299.
18. Lassegue B, Alexander RW, Clark M, Akers M, Griendling KK. Phosphatidylcholine is a major source of phosphatidic acid and diacylglycerol in angiotensin II-stimulated vascular smooth muscle cells. Biochem J. 1993;292:509-517.
19. Bornfeldt KE, Raines EW, Nakano T, Graves LM, Krebs EG, Ross R. Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J Clin Invest. 1994;93:1266-1274.
20. Parthasarathy S. Evidence for an additional intracellular site of action of probucol in the prevention of oxidative modification of low density lipoprotein. J Clin Invest. 1992;89:1618-1621.
21. Vinson JA, Starez ME, Bose P, Kassan HM, Basalyga BS. In vitro and in vivo reduction of erythrocyte sorbitol by ascorbic acid. Diabetes. 1989; 38:1036-1041.
22. Ohara Y, Peterson TE, Zheng B, Kuo JF, Harrison DG. Lysophosphatidyl choline increases vascular superoxide anion via protein kinase C activation. Arterioscler Thromb Vasc Biol. 1994;14:1007-1013.
23. Williams B, Schrier RW. Characterization of glucose-induced in situ protein kinase C activity in cultured vascular smooth muscle cells. Diabetes. 1992;41:1464-1472.
24. Farese RV, Standaert M, Yu B, Hernandez H, Cooper DR. 2-Hydroxypropyl-β-cyclodextrin enhances phorbol ester effects on glucose transport and/or protein kinase C-β translocation to the plasma membrane in rat adipocytes and soleus muscles. J Biol Chem. 1993;268: 19949-19955.
25. Hansen PA, Corbett JA, Holloszy JO. Phorbol esters stimulate muscle glucose transport by a mechanism distinct from the insulin and hypoxia pathways. Am J Physiol. 1997;273(Endocrinol Metab 36):E28-E36.
26. Kunisaki M, Bursell SE, Umeda F, Nawata H, King GL. Normalization of diacylglycerol-protein kinase C activation by vitamin E in aorta of diabetic rats and cultured rat smooth muscle cells exposed to elevated glucose levels. Diabetes. 1994;43:1372-1377.